Investment area
Venture Investments
Region
North America
Date of investment
May 2023
Octave is a modern behavioral health practice creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics, the company offers personalized care plans that can include individual, couples, and family therapy, while pioneering relationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
Contact
Eric M. Snyder
Partner
Departments: Venture Investments, Novo Holdings US Inc.
Eric joined Venture Investments (US) Inc. in March, 2018.
Previously, Eric was a managing director for Navigant Consulting, a strategic consulting firm supporting life science companies and investors, based in New York. Before joining Navigant, he worked as a management consultant for McKinsey and Leerink Partners Consulting, as well as in the global market analytics team at Pfizer with a focus on business development.
Eric earned a PhD in Neuroscience from Brown University and conducted post-doctoral studies at the Fisher Center for Alzheimer’s Disease at Rockefeller University.
